Cheang MC - Search Results

1

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies.

Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J, Cheang MC, Gelmon K, Nielsen TO, Blomqvist C, Heikkilä P, Heikkinen T, Nevanlinna H, Akslen LA, Bégin LR, Foulkes WD, Couch FJ, Wang X, Cafourek V, Olson JE, Baglietto L, Giles GG, Severi G, McLean CA, Southey MC, Rakha E, Green AR, Ellis IO, Sherman ME, Lissowska J, Anderson WF, Cox A, Cross SS, Reed MW, Provenzano E, Dawson SJ, Dunning AM, Humphreys M, Easton DF, García-Closas M, Caldas C, Pharoah PD, Huntsman D. Blows FM, et al. Among authors: cheang mc. PLoS Med. 2010 May 25;7(5):e1000279. doi: 10.1371/journal.pmed.1000279. PLoS Med. 2010. PMID: 20520800 Free PMC article.

2

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin.

Nielsen TO, Andrews HN, Cheang M, Kucab JE, Hsu FD, Ragaz J, Gilks CB, Makretsov N, Bajdik CD, Brookes C, Neckers LM, Evdokimova V, Huntsman DG, Dunn SE. Nielsen TO, et al. Cancer Res. 2004 Jan 1;64(1):286-91. doi: 10.1158/0008-5472.can-03-1242. Cancer Res. 2004. PMID: 14729636

3

The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis.

Dabiri S, Huntsman D, Makretsov N, Cheang M, Gilks B, Bajdik C, Gelmon K, Chia S, Hayes M. Dabiri S, et al. Mod Pathol. 2004 Jun;17(6):690-5. doi: 10.1038/modpathol.3800094. Mod Pathol. 2004. PMID: 15044916 Free article.

4

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.

Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM. Nielsen TO, et al. Clin Cancer Res. 2004 Aug 15;10(16):5367-74. doi: 10.1158/1078-0432.CCR-04-0220. Clin Cancer Res. 2004. PMID: 15328174

5

Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma.

Makretsov NA, Huntsman DG, Nielsen TO, Yorida E, Peacock M, Cheang MC, Dunn SE, Hayes M, van de Rijn M, Bajdik C, Gilks CB. Makretsov NA, et al. Among authors: cheang mc. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6143-51. doi: 10.1158/1078-0432.CCR-04-0429. Clin Cancer Res. 2004. PMID: 15448001

6

Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival.

Wiseman SM, Makretsov N, Nielsen TO, Gilks B, Yorida E, Cheang M, Turbin D, Gelmon K, Huntsman DG. Wiseman SM, et al. Cancer. 2005 May 1;103(9):1770-7. doi: 10.1002/cncr.20970. Cancer. 2005. PMID: 15770691 Free article.

7

Assessment of Her-1, Her-2, And Her-3 expression and Her-2 amplification in advanced stage ovarian carcinoma.

Lee CH, Huntsman DG, Cheang MC, Parker RL, Brown L, Hoskins P, Miller D, Gilks CB. Lee CH, et al. Among authors: cheang mc. Int J Gynecol Pathol. 2005 Apr;24(2):147-52. doi: 10.1097/01.pgp.0000152026.39268.57. Int J Gynecol Pathol. 2005. PMID: 15782071

8

NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis.

Prentice LM, Shadeo A, Lestou VS, Miller MA, deLeeuw RJ, Makretsov N, Turbin D, Brown LA, Macpherson N, Yorida E, Cheang MC, Bentley J, Chia S, Nielsen TO, Gilks CB, Lam W, Huntsman DG. Prentice LM, et al. Among authors: cheang mc. Oncogene. 2005 Nov 10;24(49):7281-9. doi: 10.1038/sj.onc.1208892. Oncogene. 2005. PMID: 16027731

9

TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays.

Liu CL, Montgomery KD, Natkunam Y, West RB, Nielsen TO, Cheang MC, Turbin DA, Marinelli RJ, van de Rijn M, Higgins JP. Liu CL, et al. Among authors: cheang mc. Mod Pathol. 2005 Dec;18(12):1641-8. doi: 10.1038/modpathol.3800491. Mod Pathol. 2005. PMID: 16258508 Free article.

10

MDM2 protein expression is a negative prognostic marker in breast carcinoma.

Turbin DA, Cheang MC, Bajdik CD, Gelmon KA, Yorida E, De Luca A, Nielsen TO, Huntsman DG, Gilks CB. Turbin DA, et al. Among authors: cheang mc. Mod Pathol. 2006 Jan;19(1):69-74. doi: 10.1038/modpathol.3800484. Mod Pathol. 2006. PMID: 16258514 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page